Clinical Trials Directory

Trials / Completed

CompletedNCT04071496

Diagnostic of Chronic Thrombocytopenia

Development of an Approach for the Differential Diagnosis of Chronic Idiopathic Thrombocytopenic Purpura and Congenital Thrombocytopenia

Status
Completed
Phase
Study type
Observational
Enrollment
158 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this study is to provide simple and relevant clinical and biological elements to distinguish a possible Congenital Thrombocytopenia from a Chronic Idiopathic Thrombocytopenic Purpura .

Detailed description

Congenital Thrombocytopenia is a group of rare diseases, often unrecognized and misdiagnosed as Chronic Idiopathic Thrombocytopenic Purpura. These Chronic Idiopathic Thrombocytopenic Purpura, which are exclusion diagnoses, are most often treated with corticosteroids or intravenous immunoglobulins and sometimes, when thrombocytopenia is refractory, splenectomy is performed. Currently, it is often before a case of thrombocytopenia refractory to the treatment of the dysimmunity syndrome that the notion of Congenital Thrombocytopenia is evoked. The percentage of false diagnoses (misdiagnosed Chronic Idiopathic Thrombocytopenic Purpura diagnoses) seems to represent to date 10 to 20% of cases. The objective of this study is to provide simple and relevant clinical and biological elements to distinguish a possible Congenital Thrombocytopenia from a Chronic Idiopathic Thrombocytopenic Purpura.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples1 dry tube of 5 ml, 3 citrated tubes of 5 ml, 1 tube citrate dextrose acid of 7 ml

Timeline

Start date
2009-11-25
Primary completion
2012-03-12
Completion
2012-03-12
First posted
2019-08-28
Last updated
2019-08-28

Source: ClinicalTrials.gov record NCT04071496. Inclusion in this directory is not an endorsement.